Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials

To evaluate the impact of reduction in geographic atrophy (GA) lesion growth on visual acuity in the GATHER trials using categorical outcome measures. Randomized, double-masked, sham-controlled phase 3 trials. Aged ≥50 years with noncenter point-involving GA and best-corrected visual acuity (BCVA) o...

Ausführliche Beschreibung